Arch Therapeutics (ARTH)
(Delayed Data from OTC)
$0.93 USD
-0.09 (-8.42%)
Updated May 3, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Bottom 40% (150 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.57 | 9.99 |
Current Quarter Estimate | NA | 3.93 | 57.00 |
Year Ago Quarter Estimate | 0.21 | 3.85 | 52.54 |
Next Quarter Estimate | NA | 3.92 | 61.00 |
Next Year Estimate | NA | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 13.60 | 15.70 |
Next Year | NA | 22.60 | 9.30 |
Last 5 Years | NA | 10.00 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | NA | 2.35 |
Price/Cash Flow (MRFY) | NA | 15.02 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -6,809.45% | 11.04% |
Return on Equity (TTM) | NA | 12.91% |
Debt to Equity (MRQ) | NA | 12.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.